Petrillo, Marco
 Distribuzione geografica
Continente #
EU - Europa 1.993
NA - Nord America 1.927
AS - Asia 366
AF - Africa 19
SA - Sud America 15
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 4.328
Nazione #
US - Stati Uniti d'America 1.923
DE - Germania 891
SE - Svezia 341
CN - Cina 242
UA - Ucraina 158
IT - Italia 143
FR - Francia 116
IE - Irlanda 92
PL - Polonia 75
GB - Regno Unito 73
IN - India 52
FI - Finlandia 43
TR - Turchia 37
RU - Federazione Russa 21
BE - Belgio 15
CI - Costa d'Avorio 15
IR - Iran 9
HK - Hong Kong 7
BR - Brasile 6
NL - Olanda 6
CL - Cile 5
CH - Svizzera 4
NO - Norvegia 4
AU - Australia 3
CA - Canada 3
EU - Europa 3
JP - Giappone 3
PE - Perù 3
AT - Austria 2
BD - Bangladesh 2
CZ - Repubblica Ceca 2
GR - Grecia 2
MA - Marocco 2
NG - Nigeria 2
SG - Singapore 2
A1 - Anonimo 1
AM - Armenia 1
AR - Argentina 1
BG - Bulgaria 1
CY - Cipro 1
EE - Estonia 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
IQ - Iraq 1
IS - Islanda 1
KR - Corea 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MX - Messico 1
MY - Malesia 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 4.328
Città #
Chandler 568
Ashburn 134
Jacksonville 117
San Mateo 100
Dublin 92
Nürnberg 74
Wilmington 73
Warsaw 72
Nanjing 70
Ann Arbor 66
Dearborn 51
New York 49
Marseille 47
Boston 36
Cattolica 35
Izmir 35
Houston 34
Lawrence 29
Princeton 27
Beijing 26
Redwood City 20
Hangzhou 19
Kunming 17
Seattle 17
Boardman 16
Lancaster 16
Los Angeles 16
Abidjan 15
Brussels 15
Fairfield 15
Mountain View 15
Nanchang 14
Norwalk 14
Woodbridge 13
Bremen 12
Changsha 12
Hebei 12
Leawood 12
Rome 12
Shenyang 12
Tianjin 12
University Park 12
Milan 10
Detroit 9
Falls Church 9
Redmond 8
Bucchianico 7
Chicago 7
Hefei 7
Helsinki 7
Jiaxing 7
Edinburgh 6
Munich 6
Jinan 5
Millbury 5
São Paulo 5
Wuhan 5
Amsterdam 4
Augusta 4
Cambridge 4
Fremont 4
Genazzano 4
Guangzhou 4
Hong Kong 4
Saint Petersburg 4
Busto Arsizio 3
Clearwater 3
Indiana 3
Kish 3
Lanzhou 3
Lima 3
Moscow 3
Mumbai 3
Simi Valley 3
Andover 2
Ardabil 2
Buffalo 2
Chengdu 2
Desio 2
Katsina 2
Monza 2
Oujda 2
Parma 2
Perugia 2
Phoenix 2
Polska 2
Pune 2
Sacramento 2
San Jose 2
Shanghai 2
Singapore 2
Volgograd 2
Washington 2
Yellow Springs 2
Zhengzhou 2
Zurich 2
Almaty 1
Athens 1
Auckland 1
Bern 1
Totale 2.263
Nome #
Prognostic role of topoisomerase-IIalpha in advanced ovarian cancer patients 241
Evaluation of quality of life and emotional distress in endometrial cancer patients: A 2-year prospective, longitudinal study 179
Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: long-term results 164
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 156
Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradiotherapy 146
Prognostic role of Ca125 response criteria and RECIST criteria: analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancer. 124
Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: A retrospective analysis 123
Influence of Intraperitoneal Dissemination Assessed by Laparoscopy on Prognosis of Advanced Ovarian Cancer: An Exploratory Analysis of a Single-Institution Experience 121
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 118
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 117
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study 109
A complete pathological response to treatment in a young patient with locally advanced minimal deviation adenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 105
Incidence and predictive factors for complications after uterine leiomyoma embolization 103
Secondary malignancies of the uterine cervix: a potential diagnostic pitfall 100
Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients 98
Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study 97
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 94
Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma 90
Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: A case-control study on survival in patients with two year follow-up 83
Minimally invasive versus standard laparotomic interval debulking surgery in ovarian neoplasm: A single-institution retrospective case-control study 80
Fertility-sparing surgery in ovarian cancer extended beyond the ovaries: a case report and review of the literature 76
Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study 75
Targeting the hallmarks of ovarian cancer: The big picture 75
Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis 74
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsie 74
FOXL2 molecular status in adult granulosa cell tumors of the ovary: A study of primary and metastatic cases 67
Laparoscopic En Bloc Right Diaphragmatic Peritonectomy for Diaphragmatic Endometriosis According to the Sugarbaker Technique 67
Time trade-off procedure for measuring health utilities loss with human papillomavirus-induced diseases: a multicenter, retrospective, observational pilot study in Italy 62
Polarisation of Tumor-Associated Macrophages toward M2 Phenotype Correlates with Poor Response to Chemoradiation and Reduced Survival in Patients with Locally Advanced Cervical Cancer. 62
Robotic Total Mesometrial Resection versus Laparoscopic Total Mesometrial Resection in Early Cervical Cancer: A Case-Control Study 61
Ovarian low and high grade serous carcinomas: hidden divergent features in the tumor microenvironment 61
A combined ANXA2-NDRG1-STAT1 gene signature predicts response to chemoradiotherapy in cervical cancer 59
Robotic Versus Laparoscopic Staging for Early Ovarian Cancer: A Case Matched Control Study 58
Uncovering the role of nuclear Lysyl oxidase (LOX) in advanced high grade serous ovarian cancer 58
Survivin protein as predictor of pathologic response in patients with locally advanced cervical cancer treated with chemoradiation followed by radical surgery 55
Non-catalytic region of tyrosine kinase adaptor protein 2 (NCK2) pathways as factor promoting aggressiveness in ovarian cancer 55
Neoadjuvant Chemotherapy Followed by Maintenance Therapy With or Without Bevacizumab in Unresectable High-Grade Serous Ovarian Cancer: A Case-Control Study 53
Identification and antitumor activity of a novel inhibitor of the NIMA-related kinase NEK6 53
The relevance of prelamin A and RAD51 as molecular biomarkers in cervical cancer 52
Self-Reported Long-Term Autonomic Function After Laparoscopic Total Mesometrial Resection for Early-Stage Cervical Cancer: A Multicentric Study 50
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsies 48
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 48
Long-Term Survival for Platinum-Sensitive Recurrent Ovarian Cancer Patients Treated with Secondary Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC) 47
Preoperative serum human epididymis protein 4 levels in early stage endometrial cancer: A prospective study 47
Preoperative Anti-Class III β-Tubulin Antibodies As Relevant Clinical Biomarkers in Ovarian Cancer 47
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 46
Systematic Review of Cytoreductive Surgery and Bevacizumab-Containing Chemotherapy in Advanced Ovarian Cancer: Focus on Safety 46
Secondary cytoreduction in ovarian cancer: who really benefits? 44
Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: utility of a scoring system to predict outcomes 43
The safety of bevazicumab for the treatment of ovarian cancer 42
Laparoscopic laterally extended endopelvic resection procedure for gynecological malignancies 42
Cytoreductive surgery plus platinum-based hyperthermic intraperitoneal chemotherapy in epithelial ovarian cancer: A promising integrated approach to improve locoregional control 41
RE: Pattern of and reason for postoperative residual disease in patients with advanced ovarian cancer following upfront radical debulking surgery 38
Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective study 35
Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study 34
Incidence, predictors and clinical outcome of pancreatic fistula in patients receiving splenectomy for advanced or recurrent ovarian cancer: a large multicentric experience 33
Role of extracellular vesicles in epithelial ovarian cancer: A systematic review 32
Restructuring surgical training after COVID-19 pandemic: A nationwide survey on the Italian scenario on behalf of the Italian polyspecialistic young surgeons society (SPIGC) 12
Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers 5
Totale 4.425
Categoria #
all - tutte 14.258
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.258


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019120 0 0 0 0 0 0 0 0 0 35 65 20
2019/2020605 130 32 48 15 35 56 74 24 39 35 80 37
2020/2021377 28 37 15 25 58 15 48 9 41 19 73 9
2021/2022618 52 25 11 43 35 25 10 98 40 57 92 130
2022/20231.263 154 203 118 225 53 171 66 75 141 11 28 18
2023/2024377 28 142 8 22 11 73 41 13 9 30 0 0
Totale 4.425